1. Market Research
  2. > Pharmaceutical
  3. > Therapy Market Trends
  4. > North America Cancer Vaccines Market - Segment by type, technology, end-user and geography (2015-2020)

Cancer vaccines are biological preparations that stimulate or strengthen a person's immune system against cancer. Cancer vaccines are usually administered intravenously. They can be used for both adults and children. The vaccines can be broadly classified into prophylactic and therapeutic vaccines. Prophylactic vaccines are used for the prevention of cancer, whereas therapeutic vaccines are used for treatment of the disease. Mordor Intelligence analysts forecast the North America cancer vaccines market to grow at a CAGR of 12-20% over the period 2015-2020. The North America market is currently estimated to be valued at USD 1405 million for the year 2015.

The market for cancer vaccines is much smaller than other cancer therapeutic categories. The size of the market can be attributed to the nascent stages of industry life cycle and the late introduction of the vaccines in the market. To tap this market, many companies from North America are actively investing in cancer vaccine development. The market penetration is expected to increase with the increase in competition among the various pharmaceutical companies to obtain a larger portion of this market.

The North America Cancer Vaccines Market is segmented based on:

Subunit Vaccines
Live Attenuated Vaccines
Conjugate Vaccines
Inactivated Vaccines
Recombinant Vector Vaccines
Toxoid Vaccines
Synthetic Vaccines
Dendritic Cell Vaccines
Preventive Vaccines
Therapeutic Vaccines
Disease Indication
Cervical cancer
End user

According to the World Health Organization, 14-million incidences of cancer and 8.2-million cancer deaths were recorded in 2012. Lung, prostate, colorectal, cervical, and breast cancers remain the most common forms of cancer. Thus, there is a rise in demand for vaccines to prevent and treat cancers.

North America dominates the market, with U.S. accounting for a major market share. However, it is poised to grow at the second highest CAGR during the forecast period owing to governmental initiatives, rising focus of major players on the Indian vaccine technology market, and increasing immunization initiatives by organizations such as World Health Organization and GAVI in these regions.

Some of the key participants in the industry include Prima BioMed, GlaxoSmithKline, Sanofi S.A, Merck, Aduro BioTech, AstraZeneca plc, OXFORD BIOMEDICA etc.


Increasing cancer cases
Technological developments
Drug innovations with regard to the cancer
Government initiatives
Rise in aging populace
Advanced health care services
Upsurge in awareness about cancer and their available therapies in the market
Increasing health care expenditure


Cold chain, or temperature-controlled supply chain, management
Low accessibility to vaccines in remote areas
Stringent regulatory procedures

Table Of Contents

North America Cancer Vaccines Market - Segment by type, technology, end-user and geography (2015-2020)
1. Executive Summary

2. Research Methodology

3. Introduction

3.1 Report Description

3.2 Markets Covered

4. Market Overview

4.1 Market Definition

4.2 Market Drivers

4.2.1 Increased Prevalence of Cancers

4.2.2 Rising Government and Non-Government Funding for Vaccine Development

4.2.3 Increasing Investments By Companies

4.2.4 Technological Advancements

4.3 Market Restraints

4.3.1 Cold Chain Management

4.3.2 Huge Capital Investments

4.3.3 Stringent Regulatory Procedures

4.4 Market Opportunitites

4.5 Market Threats

5. Porters Five Force Analysis

5.1 Bargaining Power of suppliers

5.2 Bargaining power of buyers

5.3 Degree of competition

5.4 Threat of substitution

5.5 Threat of new entrants

6. Market Segmentation

6.1 By Technology

6.1.1 Subunit Vaccines

6.1.2 Live Attenuated Vaccines

6.1.3 Conjugate Vaccines

6.1.4 Inactivated Vaccines

6.1.5 Recombinant Vector Vaccines

6.1.6 Toxoid Vaccines

6.1.7 Synthetic Vaccines

6.1.8 Dendritic Cell Vaccines

6.2 By Type

6.2.1 Preventive Vaccines

6.2.2 Therapeutic Vaccines

6.3 By Disease Indication

6.3.1 Cervical cancer

6.3.2 Others

6.4 By End User

6.4.1 Pediatrics

6.4.2 Adults

6.5 By Geography

6.5.1 US

6.5.2 Mexico

6.5.3 Canada

7. Competitive Landscape

7.1 Mergers and Acquisitions

7.2 Agreements, Collaborations and Partnerships

7.3 New Product Launches

7.4 Recommendations to new market players

7.5 Value Chain Analysis

8. Company Profiles

8.1 AstraZeneca plc

8.2 Aduro BioTech

8.3 Cytos

8.4 Galena Biopharma

8.5 Juvaris Biotherapeutics

8.6 MedImmune

8.7 Oxford BioMedica

8.8 Prima BioMed

8.9 GlaxoSmithKline

8.10 Sanofi

8.11 Merkandco

8.12 Ubivac

8.13 Vaccinogen

9. Appendix

9.1 Abbrevations

9.2 Sources

9.3 Bibliography

9.4 Disclaimer

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
Prostate Cancer Pricing, Reimbursement, and Access

Prostate Cancer Pricing, Reimbursement, and Access

  • $ 7 500
  • Industry report
  • July 2016
  • by Datamonitor Healthcare

Novel antiandrogens will need to present risk-sharing agreements in EU markets, while discussing contracting with US payers to ensure a competitive advantage. Vaccines suffer from inconclusive response ...

Veterinary/Animal Vaccines Market Product,, Poultry, Aquaculture, Diseases, Technology - Forecast to 2021

Veterinary/Animal Vaccines Market Product,, Poultry, Aquaculture, Diseases, Technology - Forecast to 2021

  • $ 5 650
  • Industry report
  • August 2016
  • by MarketsandMarkets

“Veterinary/Animal Vaccines Market, Product [Porcine, (Companion-Canine), (Livestock-Bovine), Poultry, Aquaculture], Diseases [Rabies, FMD, Swine Influenza, Strangles, Furunculosis], Technology [DNA, ...

Cancer Immunotherapy Market by Type, Application, End User - Global Forecast to 2021

Cancer Immunotherapy Market by Type, Application, End User - Global Forecast to 2021

  • $ 5 650
  • Industry report
  • September 2016
  • by MarketsandMarkets

The global cancer immunotherapy market is expected to reach USD 119.39 billion by 2021 from USD 61.97 billion in 2016, at a CAGR of 14.0% from 2016 to 2021. Factors such as increasing incidence of cancer, ...

Global Veterinary Vaccines Market

October 2016 $ 4 250

Download Unlimited Documents from Trusted Public Sources

Opioid Market in the US

  • October 2016
    32 pages
  • Opioid  


    Infectious Dise...  

  • United States  



View report >

The future of the Vaccine Industry

  • October 2016
    3 pages
  • Vaccine  

  • United Kingdom  



View report >

Infectious Disease Statistics and Therapy Market in the US

  • October 2016
    77 pages
  • Infectious Dise...  



  • United States  

View report >

Related Market Segments :



Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.